24.10.2012
- The Greek government, battling a shortage of many medicines, has suspended all drug exports in the wake of a fresh round of price cuts, according to a notice from the country's...
24.10.2012
- Amgen on Tuesday reported higher-than-expected third-quarter profit in its first full quarter under Chief Executive Robert Bradway and it raised its full-year earnings and revenue...
23.10.2012
- Lonza and OncoMed Pharmaceuticals, a clinical-stage biopharmaceutical company dedicated to improving cancer treatment, announced today an agreement for the development and...
23.10.2012
- Europe's drugs regulator has started an infringement procedure against Swiss pharmaceutical group Roche Holding to investigate its alleged failure to report fully tens of thousands...
23.10.2012
- In response to client requirements, Almac's expansion of their API manufacturing facility at its European Headquarters in Craigavon, UK is near completion, and will be operational...
23.10.2012
- Cobra Biologics, the international clinical and commercial manufacturer of biologics and pharmaceuticals, announces the appointment of a new non-executive director to Cobra...
19.10.2012
- AMRI announced today that it has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing, whose parent company, Shire, is a global company...
18.10.2012
- U.S. health regulators have approved ThromboGenics's main drug, eye treatment Jetrea, clearing the way for the Belgian biotechnology company to make sustainable profits...
